| Literature DB >> 31077226 |
Yuzo Oyama1, Haruto Nishida2, Takahiro Kusaba1, Hiroko Kadowaki1, Motoki Arakane1, Kazuhisa Okamoto3, Junpei Wada4, Shogo Urabe4, Tsutomu Daa1.
Abstract
BACKGROUND: Diagnoses reflect clear cell morphologies when tumor cells have clear cytoplasm in many organs, and the nature of such clear cells is typically identified. Colorectal tubular adenoma or adenocarcinoma, conversely, rarely show clear cells, the reason for which remains uncertain. We report 2 colon tumors with clear cell components (Case 1: adenoma; Case 2: adenocarcinoma) and investigate the nature of the clear cells. CASEEntities:
Keywords: Adenocarcinoma; Clear cell change; Colon; Electron microscopy
Mesh:
Substances:
Year: 2019 PMID: 31077226 PMCID: PMC6511183 DOI: 10.1186/s13000-019-0819-z
Source DB: PubMed Journal: Diagn Pathol ISSN: 1746-1596 Impact factor: 2.644
Fig. 1Tubular adenoma with clear cell change. The striking tubule structures of the clear cells are accompanied by conventional tubular adenoma cells at low magnification with HE staining (a). The boundary between the clear cell and conventional components at high magnification with HE staining (b). The clear cell component is negative for PAS (c) and alcian blue staining (d). Both components are positive for CDX2 staining (e). The localization of CEA (f) expression is diffusely cytoplasmic for the clear cell component, and luminal cell apical for the conventional one. Ki67 labeling (g) is slightly lower in the clear cell component. d-g represent immunohistochemistry. Ultrastructural examination (h) of the boundary between the clear cell area (left) and the conventional adenoma (right) at low magnification is shown and multiple cytoplasmic lipid-like vacuoles surround the nuclei in the clear cells (i)
Antibody information
| Antibody | Clone | Company | Dilution | Conditioning |
|---|---|---|---|---|
| CK7 | OV-TL 12/30 | DAKO, Santa Clara, USA | 1:50 | Protease |
| CK20 | Ks 20.8 | DAKO, Santa Clara, USA | 1:50 | Protease |
| CDX2 | AMT28 | Novus Biologicals, Newcastle, UK | 1:50 | pH 9.0 |
| CEA | II-7 | DAKO, Santa Clara, USA | 1:40 | pH 6.0 |
| CD10 | 56C6 | Novocastra, Newcastle, UK | 1:50 | pH 6.0 overnight |
| MUC2 | Ccp58 | Novocastra, Newcastle, UK | 1:100 | pH 6.0 |
| MUC5AC | CLH2 | Abcam, Cambridge, UK | 1:1000 | |
| MUC6 | CLH5 | Novocastra, Newcastle, UK | 1:100 | pH 6.0 |
| AFP | N1501 | DAKO, Santa Clara, USA | diluted | |
| Glypican3 | 1G12 | Nichirei Bioscience, Tokyo, Japan | diluted | pH 9.0 |
| AR | AR441 | DAKO, Santa Clara, USA | 1:25 | pH 6.0 |
| Perilipin | GP29 | PROGEN, Heidelberg, Germany | 1:200 | pH 6.0 |
| Adipophilin | AP125 | Acris Antibodies, Herford, Germany | 1:10 | pH 6.0 |
| Ki67 | MIB-1 | DAKO, Santa Clara, USA | 1:50 | pH 6.0 |
| COX2 | CX-294 | DAKO, Santa Clara, USA | 1:100 | pH 9.0 |
| APC | CC-1 | Oncogene, California, USA | 1:20 | pH 6.0 |
CK Cytokeratin, CDX2 Caudal type homeobox 2, CEA Carcinoembryonic antigen, CD Cluster differentiation, MUC Mucin, AFP Alpha fetoprotein, AR Androgen receptor, COX2 Cyclooxygenase 2, APC Adenomatous polyposis coli
Fig. 2Clear cell adenocarcinoma. Low magnification (a) and high magnification of the clear cell (b) and conventional components (c) with HE staining. The boundary (d) between the clear cell and conventional components at high magnification with HE staining. The clear cells are negative for PAS (e) and alcian blue staining (f), whereas both components of the tumor are positive for CDX2 (g). The localization of CEA (h) expression is diffusely cytoplasmic for the clear cell component and luminal cell apical for the conventional component. CD10 (i) and adipophilin (j) expression is confined to the clear component and Ki67 labeling (k) is higher in the clear cell component. g-k represent immunohistochemistry. Immunoelectron microscopy analysis (l) at low (left) and high magnification (right) reveals multiple cytoplasmic lipid-like vacuoles in clear cells that are negative for adipophilin
Clinicopathological information for 20 colorectal adenomas with clear cell components
| AuthorRef | Age | Sex | Location | Size (cm) | PAS | Alcian blue | Prognosis |
|---|---|---|---|---|---|---|---|
| Reed et al. [ | ND | ND | ND | ND | ND | ND | |
| Jewell et al. [ | 61 | F | R | 2 | – | – | Alive |
| Suzuki et al. [ | 62 | M | D | 1.4 | – | – | Alive |
| Domoto et al. [ | 54 | M | S | 6 | – | Scattered | |
| 45 | M | T | 6 | – | Scattered | ||
| 44 | M | S | 10 | – | Scattered | ||
| Eloy et al. [ | 48 | F | T | 2.5 | ND | – | |
| 68 | F | S | 0.5 | ND | – | ||
| 84 | M | S | 1.8 | ND | – | ||
| Shi et al. [ | ND | ND | ND | 0.8 | ND | ND | |
| 61 | M | S | 1.5 | ND | ND | ||
| ND | ND | ND | 1.8 | ND | ND | ||
| 63 | F | As | 0.5 | – | ND | ||
| 63 | M | R | 1.4 | – | ND | ||
| 68 | F | ND | 3.5 | – | ND | ||
| 30 | F | S | 1.4 | – | ND | ||
| 35 | M | S | 1.3 | ND | ND | ||
| Yao [ | 48 | M | S | 0.8 | – | – | |
| Miyasaka et al. [ | 63 | M | As, D, R | ND | – | – | |
| Present study | 75 | M | R | 1.8 | – | – | Alive |
M Male, F Female, As Ascending colon, T Transverse colon, D Descending colon, S Sigmoid colon, R Rectum, ND No data
Clinicopathological information for 24 colorectal adenocarcinomas with clear cell components
| AuthorRef | Age | Sex | Location | Size (cm) | PAS | Alcian blue | Prognosis |
|---|---|---|---|---|---|---|---|
| Hellstrom and Fisher [ | 67 | M | R | 2 | −/+ | – | Alive |
| Reed et al. [ | 71 | M | T | 7 | + | ND | |
| Jewell et al. [ | 75 | M | S | 0.1 | – | – | Died |
| 56 | F | S | 6 | ND | – | ND | |
| Watson [ | 58 | M | AC | 3.5 | + | – | Died |
| Rubio [ | 68 | M | D | 6 | −/+ | – | Died |
| Furman and Lauwers [ | ND | ND | R | ND | + | ND | ND |
| Braumann et al. [ | 89 | M | T | 2.2 | – | – | Died |
| Mallik and Katchy [ | 36 | F | R | 5 | + | + | ND |
| Ko et al. [ | 62 | M | S | 1.5 | ND | ND | ND |
| Hao et al. [ | 37 | M | D | 12 | + | – | Alive |
| Barisella et al. [ | 54 | M | As | 0.9 | ND | ND | Alive |
| Soga et al. [ | 71 | F | S | 0.8 | – | – | ND |
| Bressenot et al. [ | 84 | F | D | 3.5 | – | – | Alive |
| Shi et al. [ | 52 | M | R | 0.9 | – | ND | ND |
| 51 | M | S | 1.4 | – | ND | ND | |
| Furuya et al. [ | 81 | M | As | 9.5 | + | ND | Died |
| Barrera-Maldonado et al. [ | 41 | F | D | 3.4 | ND | ND | ND |
| Wang et al. [ | 26 | M | T | 12 | ND | ND | Died |
| Thelin et al. [ | 25 | M | As | 3 | ND | ND | Died |
| Remo et al. [ | 58 | M | As | 7 | ND | ND | Died |
| 79 | M | As | 4.5 | ND | ND | Died | |
| Tochio et al. [ | 48 | M | D | 0.7 | – | – | Alive |
| This study | 58 | M | S | 2.5 | – | – | Alive |
M Male, F Female, As Ascending colon, T Transverse colon, D Descending colon, S Sigmoid colon, R Rectum, AC Anal canal, ND No data